The American College of Allergy, Asthma, and Immunology's annual meeting provides takeaways for attendees to implement quickly in their practice to improve patient care.
Digital Tools Reduce Asthma-Related Emergency Visits, Accurately Debunks Allergy Myths
Posters presented at ACAAI 2023 Annual Scientific Congress assessed digital health tools to improve asthma self-management.
Dr Richard Wasserman on Changing Attitudes Toward Food Allergy OIT
Richard Wasserman, MD, PhD, an allergist and immunologist with Allergy Partners of North Texas, an early adopter of food allergy oral immunotherapy (OIT), discusses how attitudes have changed around the practice.
For Optimal Cost-effectiveness, Strategize Biologic Therapy for Severe Asthma
To avoid bankrupting health care, providers must carefully consider how they use biologics in patients with severe asthma, according to a presenter at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
To Prevent the Next Pandemic, Fight Antiscience Beliefs, Hotez Says
While low- and middle-income countries remain desperate for a COVID-19 vaccine, the United States has entered a dangerous new phase of the pandemic, where antivaccine forces are exporting their antiscience beliefs to other countries, according to a keynote speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Dr Carina Venter on the Gut Microbiome’s Role in Allergic Disease
Carina Venter, PhD, RD, allergy specialist dietitian and associate professor in pediatric allergy and immunology at Children's Hospital Colorado and the University of Colorado, discusses the gut microbiome’s complex relationship with our immune system and diet diversity’s potential role in allergic disease and food allergy–related outcomes.
Gaps in Anaphylaxis Care, Epinephrine Use Highlight Resource Need
An afternoon session at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting focused on key updates in pediatric anaphylaxis from the past year as seen in published data.
Let’s Talk About This Infodemic of Misinformation, Experts Agree
Misinformation is not supported by the data on the science of vaccination, agreed experts during “Combating Misinformation in Science,” which took place at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Dr Brian T. Kelly on Recognizing EoE, Non-IgE–Mediated Food Allergies
Brian T. Kelly, MD, MA, FACAAI, Midwest Allergy and Asthma Clinic, and the American College of Allergy, Asthma & Immunology annual meeting program chair, discusses the importance of distinguishing between non–immunoglobulin E (IgE)– and IgE-mediated food allergies, as well as remaining up to date on guidance for eosinophilic esophagitis (EoE).
Dr Peter Hotez Addresses How to Optimally Overcome Antivaccination Sentiment
Peter Hotez, MD, PhD, FASTMH, professor of pediatrics and molecular virology and dean, National School of Tropical Medicine, Baylor College of Medicine, and codirector, Texas Children’s Hospital Center for Vaccine Development, addresses antivaccination sentiment and how to overcome it to find an optimal solution to end the COVID-19 pandemic.
In AD Biologics Debate, Therapy Choice Is Just Half of the Battle
With new and expected future options for treating atopic dermatitis (AD), including an injectable biologic and an oral small molecule inhibitor, which is preferred and which makes the most sense for patients?
Dr Ruchi Gupta on Getting Peanut Introduction Feeding Guidelines Into Wider Practice
In 2017, guidelines about when to feed peanuts to infants changed to recommend early feeding by 4 to 6 months of age depending on 3 risk levels, but these allergy prevention strategies are still not widespread, according to Ruchi Gupta, MD, MPH, professor of pediatrics and medicine, Northwestern Feinberg School of Medicine, who discussed the topic at the 2021 ACAAI Annual Scientific Meeting.
Experts Explore Disparities in Atopic Dermatitis
Two experts explore disparities in atopic dermatitis by age, skin color, and ethnicity.
Dr Jonathan Silverberg on Using Small Molecule Inhibitors in Atopic Dermatitis
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences, discusses how small molecule inhibitors are used in atopic dermatitis, as well as why there is no one-size-fits approach to implementing them in practice.
Dr David R. Stukus Addresses COVID-19 Health Literacy, Vaccine Allergy Concerns
David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, discusses the connection between health literacy and lack of trust in science and also addresses allergy concerns toward COVID-19 vaccines.
Diversity and Innovation Infuse ACAAI Meeting Offerings in 2021
The 2021 ACAAI Annual Scientific Meeting, taking place virtually and in person in New Orleans, kicks off on Thursday, November 4, by focusing on dermatology and atopic dermatitis and concludes on Monday, November 8, with a final plenary session that addresses updates to several treatment guidelines.
Dr Brian T. Kelly: This Year’s ACAAI Meeting Offers Something for Everybody
Brian T. Kelly, MD, MA, FACAAI, Midwest Allergy and Asthma Clinic, and the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting program chair, discusses how this year’s conference content will demonstrate the joint themes of innovation and diversity, as well as what exciting developments presenters and attendees alike should watch for.
2 Clarke Drive Cranbury, NJ 08512